India's Leading Diagnostics brand | Presence across 19 States | 125 Labs | 2700 Patient TouchPoints | 4200+ Test Menu & Profiles. Accredited by NABL & CAP
@ravi_radio Dear Mr. Gupta, this is not the experience we want you to have with us. Kindly DM us with your registered contact number so that we may check this further. Regards, Team Metropolis
@monalac Dear Customer,
We sincerely apologise for the inconvenience caused. Kindly share your contact number via DM so that we can check the concern and add your number to our DND list to prevent further communications.
Warm Regards,
Team Metropolis
@kritika_po15589 Dear Ms. Kritika, we have received an update from our team that your reports are ready and has been shared with you. Regards, Team Metropolis
@AmitTiw73779776 Dear Mr. Amit, this is not the experience we want you to have with us. Kindly DM us with your VID number so that we may check this further. Regards, Team Metropolis
At the @ETHealthWorld Healthcare Leaders’ Summit 2026, Ms. @AmeeraShah, Promoter & Executive Chairperson, @MetropolisLab, shared her perspectives on building sustainable, purpose-led growth.
@AmitTiw73779776 Dear Mr. Amit, this is not the experience we want you to have with us. Kindly DM us with your VID number so that we may check this further. Regards, Team Metropolis
Proud Moment! 🏆
Our Managing Director, Mr. Surendran Chemmenkotil, has been recognised among India’s Impactful Healthcare Leaders 2026 by @ET_Edge , The Times Group, at the Future of Healthcare Conclave 2026 in Mumbai.
@AmitTiw73779776 Dear Mr. Amit, this is not the experience we want you to have with us. Kindly DM us with your VID number so that we may check this further. Regards, Team Metropolis
Why must adolescent agency be at the heart of sustainable social change? Dr Duru Shah, Chairperson, Metropolis Foundation, explains in an exclusive interview with The CSR universe, sharing how our ARSH programme empowers young people at the grassroots.
🔗 https://t.co/QVXTB3gUEe
@AmitTiw73779776 Dear Mr. Amit, this is not the experience we want you to have with us. Kindly DM us with your VID number so that we may check this further. Regards, Team Metropolis
@AmitTiw73779776 Dear Mr. Amit, this is not the experience we want you to have with us. Kindly DM us with your VID number so that we may check this further. Regards, Team Metropolis
Q2 FY27 at Metropolis: Revenue up 16% to ₹497 Cr | PAT up 43% | EBITDA margin at 27.2%
Our MD C Surendran speaks to @business_today TV on Tier II & III markets, specialty diagnostics and what’s next.
#MetropolisHealthcare#Q2FY27
https://t.co/UQtGSZqnmZ
@kritika_po15589 Dear Kritika, this is not the experience we want you to have with us. Kindly allow us sometime to get this checked. Regards, Team Metropolis
@msw_maverick Dear Customer, we understand your concern. Test prices may vary depending on the location and applicable operational factors. We request you to share your contact details via DM so that our team can look into your concern and assist you further. Regards, Team Metropolis
@msw_maverick Dear Customer, kindly DM us with your registered contact number and the VID number so that we may check this further. Regards, Team Metropolis
@msw_maverick Dear Customer, kindly DM us with your registered contact number and the VID number so that we may check this further. Regards, Team Metropolis
Our MD C Surendran on @ETNOWlive: FY27 revenue growth guidance of 16% on track, driven by specialty diagnostics and Tier 2/3 expansion. Also covered margins, lab-to-centre ratio, and oncology and genomics.
https://t.co/SdzDtvAnJe
@CitizenAnsari Dear Mr. Ansari, we have received an update from our team that they have spoken with you and addressed your concern. Kindly allow us some time to get this checked and resolved. Regards, Team Metropolis